Pharmacoeconomic analysis of type 2 diabetes mellitus by vildagliptin medication in Kazakhstan

Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.

dc.contributor.author	Yelekenova, A.
dc.contributor.author	Bektur, C.
dc.contributor.author	Nurgozhin, T.
dc.date.accessioned	2015-11-05T09:42:49Z
dc.date.available	2015-11-05T09:42:49Z
dc.date.issued	2014
dc.identifier.isbn	9786018046728
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/794
dc.description.abstract	This study is aimed to determine cost-effectiveness of vildagliptin in comparison with sitagliptin for the treatment of patients with type 2 diabetes mellitus (T2DM) from the perspective of Ministry of Health of the Republic of Kazakhstan.	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	Nazarbayev University	ru_RU
dc.subject	pharmacoeconomic	ru_RU
dc.subject	analysis	ru_RU
dc.subject	diabetes	ru_RU
dc.subject	metformin	ru_RU
dc.subject	therapy	ru_RU
dc.title	Pharmacoeconomic analysis of type 2 diabetes mellitus by vildagliptin medication in Kazakhstan	ru_RU
dc.type	Abstract	ru_RU